A large analysis finds people taking GLP-1 medications had fewer psychiatric-related hospital visits, though researchers say the reasons remain unclear
A large study finds that interrupting medications like semaglutide may reverse cardiovascular gains, raising questions about long-term use
New data shows adolescent obesity has increased over the past decade, while weight-loss efforts have declined, raising questions about motivation, mental health, and changing norms
A large review of global research found that adolescents who spend more time on smartphones are more likely to report emotional overeating, uncontrolled eating and dissatisfaction with their bodies.
Researchers comparing AI-generated diet plans with those created by a registered dietitian found the AI versions underestimated calorie needs and skewed macronutrient balance for adolescents trying to lose weight.
A small community study found that asking parents to document local food environments with photos helped shift how they thought about food marketing, children’s diets and the choices available to families.
An analysis of global safety reports found that the GLP-1 drug Wegovy was associated with higher reporting odds of a rare optic nerve condition known as ischemic optic neuropathy.
A scientific review finds the popular supplement does not work like GLP-1 drugs and that its metabolic effects appear to depend heavily on the gut microbiome.
In a large cohort study, fewer than 1 in 4 adults with overweight or obesity remained on a GLP-1 medication after 12 months.
Higher levels of the hormone asprosin were associated with lower odds of significant weight gain in more than 4,000 postmenopausal women.
A long-term study of college students found that people who maintained healthier patterns of diet, exercise and sleep gained less weight over the following two decades.
A meta-analysis suggests people regain much of the weight lost on medications like Ozempic and Wegovy after stopping treatment, though about one-quarter of the weight loss may persist.
Research suggests combining conventional frying with microwave heating could reduce oil absorption while keeping the crispy texture consumers expect.
A seven-day diary study finds that negative moods are linked to more unhealthy snack choices among dieters, while positive moods are associated with more snacking among non-dieters.
A new study in mice links a low-protein diet and specific gut microbes to signals that shift white fat toward energy-burning beige fat.
A new brain study finds that expectations can shape how much people enjoy sugar and artificial sweeteners, altering both perception and neural reward signals.
A new brain study suggests that visual food cues may continue to trigger reward signals even when hunger has already been satisfied.
In a virtual buffet experiment, participants selected up to 75% more calories when offered a wider range of options, even when the mix of healthy and indulgent foods stayed the same.
A study in hyperglycemic mice suggests a ketogenic diet restored aerobic adaptation to exercise, raising questions about how blood sugar may blunt training benefits.
A UK birth cohort study suggests both maternal and paternal BMI before conception may shape a child’s long-term liver health, with childhood weight playing a major role.
Long-term MRI follow-up found metabolic benefits persisted even after weight regain in structured diet programs.
A mouse study found gut and inflammation changes linked to the additive that helps semaglutide tablets work, though no human harm has been shown.
A new study suggests brief, positively framed messages may reduce immediate cravings and consumption intentions more effectively than longer ads.
A Cochrane review of 22 randomized trials suggests fasting performs similarly to standard dietary advice for adults with overweight or obesity.
New research suggests people using semaglutide often prioritize perceived results over discomfort when deciding whether to continue treatment.
